David Montani, MD, PhD is a Professor at the French National Referral Centre for Pulmonary Hypertension in the Department of Respiratory Medicine headed by Pr Marc Humbert, at the Hôpital Bicêtre, Le Kremlin-Bicêtre, Paris-Saclay University, France. His main research interest is in the field of pulmonary vascular diseases, particularly in the management of pulmonary veno-occlusive disease (PVOD), pulmonary arterial hypertension (PAH) associated with drug exposure, PAH associated with orphan pulmonary diseases, and genetics (BMPR2, ACVRL1, NF1, TBX4, SOX17) of PAH and PVOD. D. Montani has developed a screening program for pulmonary hypertension in asymptomatic subjects carrying a genetic susceptibility to PAH/PVOD in the French PAH network. He leads the centre of Rare pulmonary diseases (OrphaLung network) in Bicetre Hospital. In addition, Pr. Montani leads a basic research team in the INSERM UMR-S999 laboratory «Pulmonary Hypertension: Pathophysiology and Novel Therapies» (Centre Chirurgical Marie Lannelongue, Le Plessis Robinson), led by Prof. Marc Humbert, his work focusing on the pathophysiology of heritable and drug-induced PAH and PVOD. David Montani has published >400 articles mainly on pulmonary hypertension (genetics, drugs-associated PAH, pulmonary rare diseases, and basic science) and is Editor-in-Chief of Respiratory Medicine and Research (https://www.editorialmanager.com/resmer).